Patents matching “tablet”

US 8758818

Oral tablet compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jun 24, 2014 · Expires Jun 19, 2034

US 8753682

Dual release oral tablet compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jun 17, 2014 · Expires Jun 12, 2034

US 8697125

Tablet preparation without causing a tableting trouble

Takeda Pharmaceutical Company Limited · Granted Apr 15, 2014 · Expires Apr 10, 2034

US 8642081

Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance

TAKEDA NYCOMED AS · Granted Feb 4, 2014 · Expires Jan 30, 2034

US 8642649

Orally dispersible tablet

Takeda Pharmaceutical Company Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

US 8642648

Orally dispersible tablet

Takeda Pharmaceutical Company Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

US 8563035

Oral tablet compositions of dexlansoprazole

Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi · Granted Oct 22, 2013 · Expires Oct 17, 2033

US 8563034

Dual release oral tablet compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Oct 22, 2013 · Expires Oct 17, 2033

US 8541024

Film-coated scored tablet

Takeda Pharmaceutical Company Limited · Granted Sep 24, 2013 · Expires Sep 19, 2033

US 8426461

Orally dispersible tablet

Takeda Pharmaceutical Company Limited · Granted Apr 23, 2013 · Expires Apr 18, 2033

US 8372812

Phospholipid and protein tablets

Aker Biomarine AS · Granted Feb 12, 2013 · Expires Feb 7, 2033

US 8148560

Vaginal tablets comprising misoprostol and methods of making and using the same

TEVA WOMEN'S HEALTH, INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

DE 102010033527

Quetiapin-Tabletten

ACINO PHARMA AG [CH] · Granted Feb 9, 2012 · Expires Feb 4, 2032

US 8003126

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. · Granted Aug 23, 2011 · Expires Aug 18, 2031

US 7875292

Orally disintegrable tablets

Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

US 7611722

Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

US 7566462

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2009 · Expires Jul 23, 2029

US 7431942

Orally disintegrable tablets

Takeda Pharmaceutical Company Limited · Granted Oct 7, 2008 · Expires Oct 2, 2028

US 7387792

Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

Collegium Pharmaceutical, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

US 6863901

Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

Collegium Pharmaceutical, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

US 6589507

Foaming antacid suspension tablets

DR. Regenold GmbH · Granted Jul 8, 2003 · Expires Jul 3, 2023

US 6328994

Orally disintegrable tablets

Takeda Chemical Industries Ltd. · Granted Dec 11, 2001 · Expires Dec 6, 2021

US 6306444

Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same

BIONORICA ARZNEIMITTEL GMBH · Granted Oct 23, 2001 · Expires Oct 18, 2021

US 6117430

Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same

BIONORICA ARZNEIMITTEL GMBH · Granted Sep 12, 2000 · Expires Sep 7, 2020